© 1997 American Heart Association, Inc.
Articles |
Role of Lipoprotein-Bound NEFAs in Enhancing the Specific Activity of Plasma CETP in the Nephrotic Syndrome
From Service de Médecine V, Hôpital Henri Mondor, Créteil (S.B., C.M., B.J.); Laboratoire de Biochimie des Lipoprotéines, INSERM CJF 93-10, Faculté de Médecine, Dijon (D.M., E.F., A.A., P.G., C.L., L.L.); and Service de Néphrologie, Hôpital Henri Mondor, Créteil (G.R.), France.
Correspondence to Laurent Lagrost, Laboratoire de Biochimie Médicale, Hôpital du Bocage, BP 1542, 21034 Dijon, France.
Abstract Plasma cholesteryl ester transfer protein (CETP) activity, evaluated by the transfer of radiolabeled cholesteryl esters from a tracer dose of tritiated HDL to the plasma apolipoprotein B–containing lipoproteins, was significantly higher in patients with untreated idiopathic nephrotic syndrome (n=15) than in normolipidemic control subjects (n=22) (81.5±8.4 versus 43.1±3.1 µg CE · mL-1 · h-1, respectively; P<.001). The increased CETP activity in nephrotic plasma was explained by a significant rise in both the CETP mass concentration (3.2±0.2 versus 2.1±0.1 mg/L; P<.001), and the specific CETP activity, calculated as the ratio of CETP activity to CETP mass (25.3±1.7 versus 20.4±1.6 µg CE · mg-1 · h-1; P<.05). Elevated CETP activity in nephrotic patients was shown to be associated with a significant decrease in the mean size of LDL (24.4±0.5 versus 26.3±0.5 nm; P<.0001) as well as in the relative abundance of HDL2a (29.6±1.6% versus 34.8±1.1%; P<.05). The nephrotic syndrome was characterized by a significant increase in the relative proportion of lipoprotein-bound nonesterified fatty acids (NEFAs) (35.4±7.7% versus 7.6±3.0% of total; P<.01), leading to a significant increase in the electronegative charge of LDL (-4.3±0.1 versus -3.9±0.1 mV; P<.05) and HDL (-11.5±0.1 versus -11.1±0.2 mV; P<.05). Compared with native, nonsupplemented plasma, removal of lipoprotein-bound NEFAs by addition of fatty acid–poor albumin to total plasma from nephrotic patients or control subjects significantly decreased CETP activity and specific CETP activity. Specific CETP activity no longer differed between nephrotic and control groups after albumin supplementation (19.7±1.5 versus 17.7±1.5 µg CE · mg-1 · h-1; NS). It is concluded that, in addition to elevated CETP mass concentration, lipoprotein-bound NEFAs, by increasing the negative electrostatic charge of nephrotic lipoproteins, can facilitate the CETP-mediated neutral-lipid transfer reaction in total plasma from nephrotic patients.
Key Words: lipids • nephrosis • hypoalbuminemia • kidney • triglycerides
This article has been cited by other articles:
 |
|
 |
|
  M. Zeller, D. Masson, M. Farnier, L. Lorgis, V. Deckert, J.-P. Pais de Barros, C. Desrumaux, P. Sicard, J. Grober, D. Blache, et al. High Serum Cholesteryl Ester Transfer Rates and Small High-Density Lipoproteins Are Associated With Young Age in Patients With Acute Myocardial Infarction J. Am. Coll. Cardiol., November 13, 2007; 50(20): 1948 - 1955. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. E. Morton and D. J. Greene CETP and lipid transfer inhibitor protein are uniquely affected by the negative charge density of the lipid and protein domains of LDL J. Lipid Res., December 1, 2003; 44(12): 2287 - 2296. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. K. Dogra, S. Herrmann, A. B. Irish, M. A. B. Thomas, and G. F. Watts Insulin resistance, dyslipidaemia, inflammation and endothelial function in nephrotic syndrome Nephrol. Dial. Transplant., December 1, 2002; 17(12): 2220 - 2225. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Stamler, D. Breznan, T. A-M. Neville, F. J. Viau, E. Camlioglu, and D. L. Sparks Phosphatidylinositol promotes cholesterol transport in vivo J. Lipid Res., August 1, 2000; 41(8): 1214 - 1221. [Abstract] [Full Text]
|
|